Upstream Manufacturing Solutions
-
Dynamic & Ergonomic Oligosynthesis Column
5/6/2024
These patented synthesis columns offer oligonucleotide manufacturers a system designed for efficiency and safety.
-
Chemically Defined Supplements Designed With Performance In Mind
5/3/2024
A diverse set of fully chemically defined, animal origin–free (AOF), and protein-free cell culture supplements have been developed to help promote cell growth and boost protein production.
-
Peptones Tailored For Vaccine Production
5/3/2024
Designed for human and animal health applications, these animal origin–free and animal origin peptones can effectively to supplement a variety of cell culture media.
-
Simplify Your Peptone Screening Process With Gibco Starter Paks
5/3/2024
These widely used peptones are tailored for specific applications, including monoclonal antibodies, recombinant proteins, and vaccines, for use in mammalian cell culture and microbial fermentation.
-
Mitigate Contamination Risks With HTST Flash Pasteurization
5/2/2024
Gibco™ High-temperature, short-time (HTST) treatment of raw materials
HTST treatment currently available in North America
Simple sugar batch sizes ranging from 800 to 8,800 L
In-house HTST preparation can be expensive and cumbersome. Outsourcing this technology to Thermo Fisher Scientific can alleviate production bottlenecks and increase viral mitigation confidence.
Suitable and cost-effective for large volumes
Standard and custom bioprocessing containers available (5 L–1,000 L). Please contact your sales representative.
-
High-Quality Water Ready For Upstream And Downstream Bioprocessing
4/26/2024
Explore a high-quality, cell culture–grade water that is used in injection and various bioprocessing needs, including the production of process liquids, supplements, media, and cleaning solutions.
-
Clone, Strain, And Viral Construct Screening Executed For You
4/24/2024
Evaluate your clones, strains, and viral constructs in our bioreactors with flexible scale out.
Benefits
Select the best clone by evaluating larger experimental cohorts
Make the most informed, data-driven selection by leveraging our fleet of 250mL and 5L Culture bioreactors to screen your clones, strains and viral constructs.
Defer your capital equipment spend
Evaluate your clones, strains and viral constructs without the need for new capital equipment.
Transparent, real-time data provided by a team of experts
Painless technology transfer with live data relayed via our cloud-connected systems. We have >95% success rate with >22,000 runs successfully executed.
-
Leverage Bioreactor Capacity When You Need It With Culture Bioreactors
4/24/2024
Gain access to Culture bioreactors when you need rapid overflow experimental capacity.
Benefits
Progress studies faster
Run overflow projects and conduct parallel experiments with Culture to reduce time and alleviate bottlenecks.
Stay agile in your capacity planning
Scale your workload at Culture according to your current needs. Respond rapidly to surging demands.
Eliminate your capital equipment spend
Leverage Culture’s facility quickly to avoid building out lab space, spending capital on equipment, and hiring specialized staff.
-
Bioreactors And DOE Expertise To Characterize Your Process Prior To PPQ
4/18/2024
Assess your process in scale-down bioreactors that allow for increased model curvature and variables in your process DOEs.
-
Cutting-Edge Solution To Streamline Your CLD Workflow
4/16/2024
Discover a cutting-edge approach that enables you to screen for glycans at every stage of CLD and streamline your workflow.